Showing results (141-150 of 689) with videos related to
Sort By:
Pageof 69
Antibiotics (Basel, Switzerland)|October 27, 2022
Fidaxomicin for the Treatment of Clostridioides difficile Infection in Adult Patients: An Update on Results from Randomized Controlled TrialsDaniele Roberto Giacobbe, Antonio Vena, Marco Falcone, et al.Advances in Therapy|May 18, 2019
Efficacy and Safety of Meropenem-Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc AnalysisMatteo Bassetti, Daniele Roberto Giacobbe, Niki Patel, et al.Expert Opinion on Drug Safety|June 14, 2018
Antimicrobial resistance and treatment: an unmet clinical safety needMatteo Bassetti, Alessandro Russo, Alessia Carnelutti, et al.Intensive Care Medicine|November 9, 2019
Post-operative abdominal infections: epidemiology, operational definitions, and outcomesMatteo Bassetti, Christian Eckmann, Daniele Roberto Giacobbe, et al.Expert Opinion on Pharmacotherapy|September 11, 2020
Therapeutic options for difficult-to-treat Acinetobacter baumannii infections: a 2020 perspectiveMatteo Bassetti, Laura Labate, Chiara Russo, et al.Expert Opinion on Investigational Drugs|January 22, 2015
Delafloxacin for the treatment of respiratory and skin infectionsMatteo Bassetti, Paola Della Siega, Davide Pecori, et al.Current Opinion in Infectious Diseases|October 16, 2020
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?Matteo Bassetti, Daniele R Giacobbe, Chiara Robba, et al.Current Opinion in Infectious Diseases|October 3, 2020
The role of new antimicrobials for Gram-negative infections in daily clinical practiceMatteo Bassetti, Antonio Vena, Denise Battaglini, et al.Core Evidence|July 17, 2019
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapyMatteo Bassetti, Nadia Castaldo, Alessia Carnelutti, et al.Antibiotics (Basel, Switzerland)|September 25, 2020
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat ResistanceMatteo Bassetti, Antonio Vena, Chiara Sepulcri, et al.Pageof 69